n(6)-benzyl-cyclic adenosine 5'-monophosphate has been researched along with transforming growth factor beta in 1 studies
Studies (n(6)-benzyl-cyclic adenosine 5'-monophosphate) | Trials (n(6)-benzyl-cyclic adenosine 5'-monophosphate) | Recent Studies (post-2010) (n(6)-benzyl-cyclic adenosine 5'-monophosphate) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
---|---|---|---|---|---|
5 | 0 | 1 | 49,119 | 560 | 17,610 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beiske, K; Blomhoff, HK; Lømo, J; Smeland, EB; Stokke, T | 1 |
1 other study(ies) available for n(6)-benzyl-cyclic adenosine 5'-monophosphate and transforming growth factor beta
Article | Year |
---|---|
TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; B-Lymphocytes; Cells, Cultured; Colforsin; Cyclic AMP; DNA Damage; Humans; Lectins, C-Type; Lymphocyte Activation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thionucleotides; Transforming Growth Factor beta | 1995 |